October 23, 2017
Considered to be one of the best health-care systems in the world, Singapore is a model of quality, efficiency and affordability. Singapore provides universal health care…
October 20, 2017
We are looking forward to meeting you during the upcoming ISPOR Congress and present you the unique expertise we provide in terms of: Market access consulting, Application dossier and negotiation support…
September 18, 2017
You are welcome to participate to our Prioritis Meeting 2017. We’ll discuss the essential topical issues of the year and we’ll answer your questions (Reports of the Transparency Committee, ANSM reports, Social Security Financing Act…).
Prismaccess contains a comprehensive, detailed record of HTA authorities’ decisions extracted into easy to navigate summaries.
Prismaccess allows you to identify key data and comparator products performances allowing you to build your Pricing & Reimbursement dossier in accordance with the needs of the regulators and payers.
Prismaccess provides data and information on all pharma & biotech products during initial and subsequent evaluations by national authorities on HTA markets.
Prioritis is a global provider in market access solutions for pharmaceutical, biotechnology and medical devices. Prioritis undertakes support for pricing and reimbursement processes for new innovative drugs, extension of indications and reassessment of therapeutic areas.
Evalumade is a platform dedicated to market access leaders, offering clear top-level visual information about HTA decisions. It is a unique responsive, graphical interface constructed to facilitate the consultation and the extraction of HTA data.